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Segregation analyses aim to detect genetic factors that have a major effect on an individual’s risk of disease and
to describe them in terms of mode of inheritance, age-specific cumulative risk (penetrance), and allele frequency.
We conducted single- and two-locus segregation analyses of data from 1,476 men with prostate cancer diagnosed
at age !70 years and ascertained through population registries in Melbourne, Sydney, and Perth, Australia, and
from their brothers, fathers, and both maternal and paternal lineal uncles. Estimation and model selection were
based on asymptotic likelihood theory and were performed through use of the software MENDEL. All two-locus
models gave better fits than did single-locus models, even if lineal uncles were excluded or if we censored data (age
and disease status) for relatives at 1992, when prostate-specific–antigen testing started to have a major impact on
the incidence of prostate cancer in Australia. Among the genetic models that we considered, the best-fitting ones
included a dominantly inherited increased risk that was greater, in multiplicative terms, at younger ages, as well
as a recessively inherited or X-linked increased risk that was greater, in multiplicative terms, at older ages. The
recessive and X-linked effects were strongly confounded, and it was not possible to fit them together. Penetrance
to age 80 years was ∼70% (95% confidence interval [CI] 57%–85%) for the dominant effect and virtually 100%
for the recessive and X-linked effects. Approximately 1/30 (95% CI 1/80–1/12) men would carry the dominant
risk, and 1/140 (95% CI 1/220–1/90) would carry the recessive risk or 1/200 (95% CI 1/380–1/100) would carry
the X-linked risk. Within discussed limitations, these analyses confirm the genetic heterogeneity, of prostate cancer
susceptibility, that is becoming evident from linkage analyses, and they may aid future efforts in gene discovery.
Introduction
Having a family history of prostate cancer (CaP [MIM
176807]) is one of the few well-established risk factors
for the disease. The increased risk associated with having
at least one affected first-degree relative is approximately
twofold (Steinberg et al. 1990; Carter et al. 1992; Hayes
et al. 1995; Bratt et al. 1997, 1999; Easton et al. 1997;
Ghadirian et al. 1997). In multiplicative terms, this in-
creased risk is greater (a) the younger the age at diagnosis
in the affected relative and (b) the younger the age of
the person at risk (Gronberg et al. 1996, 1997; Bishop
and Kiemeney 1997). A similar pattern is apparent in
other cancers; for example, the existence of genes as-
sociated with a dominantly inherited high breast-cancer
risk that is greater (in multiplicative terms) at younger
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ages has been predicted by segregation analyses. These
predictions have since been confirmed by molecular
studies of the susceptibility loci BRCA1 (MIM 113705)
and BRCA2 (MIM 600185) (Ford et al. 1998).
For CaP, the increased familial risk also appears to
be greater if the affected relative is a brother rather than
a father or son (Woolf 1960; Steinberg et al. 1990; Gold-
gar et al. 1994; Hayes et al. 1995; Monroe et al. 1995;
Whittemore et al. 1995; Lesko et al. 1996; Schaid et al.
1998; Cerhan et al. 1999; Schuurman et al. 1999). A
greater risk due to an affected sibling than due to an
affected parent has been interpreted as evidence of X-
linked or recessive inheritance of CaP risk (Monroe et
al. 1995; Narod et al. 1995).
Moreover, recently published data suggest that an af-
fected twin brother is associated with an even greater
risk: 3-fold if in a DZ pair and up to 10-fold if in an
MZ pair (Gronberg et al. 1994; Page et al. 1997; Lich-
tenstein et al. 2000). There are several plausible reasons
why concordances are higher in twins than those in
nontwins, and higher still in MZ pairs. First, there may
be environmental or lifestyle factors that have an impact
on the risk and/or age at diagnosis of disease and that
are shared to a greater extent by twins than by non-
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twins. In particular, diagnosis of CaP in a brother could
spur a man to seek screening by the prostate-spe-
cific–antigen (PSA) test. The effect that diagnosis in a
sibling has on screening behavior could be stronger if
the brother is a twin rather than a nontwin and could
be stronger within MZ pairs than within DZ pairs.
There could also be genetic factors, which would ex-
plain at least part, but not necessarily all, of the excess
concordance in MZ pairs compared with DZ pairs.
Single-locus segregation analyses aim to identify the
mode of inheritance and other characteristics of the
most plausible genetic factor(s) that may have a major
effect on an individual’s risk of disease. For CaP these
analyses have typically supported the role of a rare (al-
lele frequency ∼.005) dominantly inherited set of genetic
risk factors that confer a high lifetime risk, of up to
90% by age 85 years (Carter et al. 1992; Schaid et al.
1998), although there is also a report of a more common
genetic risk (allele frequency .017), with a lower cu-
mulative probability (63% to age 85 years) (Gronberg
et al. 1997). These segregation analyses, however, have
analyzed data only from first-degree relatives of affected
probands, and, hence, their ability to differentiate be-
tween different modes of inheritance has been limited.
A recent segregation analysis suggested that a dominant
model alone cannot adequately explain family data
when probands were diagnosed at age 170 years (Schaid
et al. 1998). To the best of our knowledge, segregation
analyses considering more than one mode of inheritance
do not appear to have been published previously. Much
can be learned from segregation analyses that accom-
modate multiple sources of familial aggregation simul-
taneously and that use data from more than just nuclear
families, as we have demonstrated recently for breast
cancer (Cui et al. 2001).
During the past few years, at least six regions of the
genome have been identified that may contain loci as-
sociated with a high risk of CaP. Based on results of
previous single-locus segregation analyses, classic link-
age studies of the autosomal chromosomes have pre-
sumed dominant inheritance and have used the esti-
mates of both age-specific risk in carriers and allele
frequency quoted above. Candidate regions include the
following: 1q24-25 (the putative CaP-susceptibility lo-
cus HPC1 [MIM 601518]) (Smith et al. 1996; Cooney
et al. 1997; Hsieh et al. 1997; Xu et al. 2000), 1q42.2-
43 (PCaP [MIM 602759]) (Berthon et al. 1998), 1p36
(CAPB [MIM 603688]) (Gibbs et al. 1999), 16q23.2
(CTRB1 [MIM 118890]) (Paris et al. 2000), and, more
recently, 17p (HPC2/ELAC2 [MIM 605367]) (Rebbeck
et al. 2000; Tavtigian et al. 2000). For all of these pu-
tative autosomal loci, there also exist reports that have
failed to find evidence of linkage. There has also been
a report of a possible locus on the X chromosome, at
the region Xq27-28 (HPCX [MIM 300147]) (Xu et al.
1998). Whereas evidence for linkage to putative loci
with a presumed dominant inheritance of risk has al-
most all come from a small subset of families with CaP
that have multiple affected members, usually with early-
onset disease, recent evidence for X linkage has come
from families with fewer cases and with a later-onset
disease (Schleutker et al. 1999).
We have conducted single-locus and two-locus seg-
regation analyses of a large series of families, unselected
for family history, based on men with clinically signif-
icant CaP diagnosed at age !70 years. The families con-
sist of the proband and his father, brothers, and lineal
uncles on both sides of the family. The study was per-
formed during a period when CaP screening by the PSA
test was gaining popularity in Australia. Consequently,
we have adjusted baseline risks and have conducted
analyses in which information on relatives has been cen-
sored back to a time prior to the impact of PSA testing,
to assess the sensitivity of our model fits.
Subjects and Methods
Subjects
Data on family cancer history were collected by face-
to-face interview of participants in a population-based
case-control study of risk factors for CaP, conducted in
Melbourne, Sydney, and Perth (G. G. Giles, G. Severi,
M. R. E. McCredie, D. R. English, M. P. Staples, J. L.
Hopper, W. Johnson, P. Boyle, unpublished data). Pa-
tients were considered eligible if they were men (1) with
a first primary invasive adenocarcinoma of the prostate,
with Gleason score 14; (2) diagnosed between April 1,
1994 and December 31, 1997; (3) age at diagnosis !70
years; and (4) resident in the metropolitan areas of these
state capital cities. Patients were identified from the state
cancer registries of Victoria, New South Wales, and
Western Australia and were approached with the per-
mission of their treating urologist. In this analysis, only
data from patients (hereafter referred to as the “pro-
bands”) and their relatives were used.
Information about date of birth, vital status, and his-
tory of cancer in all first-degree relatives and in both
maternal and paternal lineal uncles was sought from
probands by means of a self-completed questionnaire.
Date at diagnosis (and, therefore, age at diagnosis) was
recorded for the proband and for all affected relatives.
Age at last interview—and age at death, if the individual
no longer was alive—were recorded for all unaffected
relatives. Information about grandfathers was not col-
lected, because it was found that few probands had re-
liable information about CaP in grandfathers. To date,
we have been able to confirm 45% (165/363) of all re-
ports of CaP in relatives, 56% (62/111) for brothers,
44% (71/163) for fathers, and 36% (32/89) for uncles.
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No false positives have been detected. The analyses be-
low are based on the proband’s report of family history.
Statistical Analysis
The cumulative probability of CaP in a defined cohort
of relatives of the probands— , where S(t)F(t)p 1 S(t)
is the survivor function—was estimated by the Kaplan-
Meier product-limit method (Kaplan and Meier 1958),
based on the disease status and censored age and cal-
culated by the statistical software STATA, release 6
(Stata Corporation). The variance of the product-limit
estimator was estimated by Greenwood’s (1926) for-
mula and was used to calculate confidence intervals. This
was performed separately for probands and their broth-
ers, fathers, and lineal uncles on both maternal and pa-
ternal sides of each family.
Complex segregation analyses were performed under
maximum-likelihood theory, by the software MENDEL
(Lange et al. 1988).We fitted what have traditionally been
called single-locus and two-locus models of “major gene”
effects with different modes of inheritance (autosomal
dominant, recessive, codominant, and X linked). To ad-
just for ascertainment, the likelihood for each pedigree
was conditioned on the proband being affected at his age
at diagnosis of CaP.
For a single-locus model, let a represent a disease allele
and assume a Mendelian mode of transmission. Let
be the population frequency of all diseasepp 1 q
alleles at this locus and assume random mating and
Hardy-Weinberg equilibrium at this locus (Elandt-John-
son 1971). Note that, despite its historic name, a single-
locus model may represent effects with the same mode
of inheritance at multiple loci, provided that, at each of
these loci, the at-risk genotype (e.g., Aa or aa for dom-
inant inheritance or aa for recessive inheritance) is so
rare that it is highly unlikely that more than one locus
contributes to this type of genetic risk in any one family.
In accordance with the studies by Ford et al. (1998)
and Cui and Hopper (2000), a proportional-hazards
model was assumed, in which the hazard function of
development of CaP at age t, in calendar year group k
( ), for a male with i disease alleles (…kp 1, 2, ,K ip
), is given by , where we set0, 1, 2 l (t,k)p HR (t)l (t,k)i i 0
, so that HRi(t) is the genetic hazard ratio atHR (t)p 10
age t (Benichou 1997) for males with i alleles, compared
with that for noncarriers. Here the hazard ratio HRi(t)
depends only on age t, not on calendar-year group
k—whereas the absolute hazard, li(t, k), is assumed to
be dependent on both age t and calendar-year group k,
to reflect the change in CaP incidences since the early
1990s, after the introduction of PSA testing.
We chose the number of calendar-year groups to be
, with l(t, 1) representing the age-specific inci-Kp 2
dence before 1992 and l(t, 2) the incidence after 1992.
This is because the incidence rate was relatively stable
before 1992 and then increased by nearly twofold from
1992 to 1996 (Giles et al. 1992, 1998; McCredie et al.
1996). Incidence rates were calculated using a population-
weighted average of age-specific rates from each of the
three states. First-, second-, third-, and fourth-order poly-
nomial functions were used to model the log hazard ratio
ln[HRi(t)]. For females, we assumed that forl (t,k)p 0i
all i.
We modeled ln[HRi(t)] as a Jth-order polynomial
function of age t, given by
J
j …ln [HR (t)]p a b (t 60) , Jp 1, ,4 , (1)i j
jp1
where exp(a) is the hazard ratio at age 60 years.
Let l(t, k) be the population incidence of CaP at age
t, in calendar-year group k. If, for simplicity, it is as-
sumed that there is no mortality difference, by genotype,
across the age ranges considered (although this could
have been implemented; e.g., see Bishop et al. [1988]),
then, for an autosomal locus, the hazard function for
noncarriers is given by
l(t,k)
l (t,k)p0 2 2(1 q )HR (t) qd
under dominant inheritance, where HR (t)p1
; byHR (t)p HR (t)2 d
l(t,k)
l (t,k)p0 2 2p HR (t) (1 p )r
under recessive inheritance, where andHR (t)p 11
; and byHR (t)p HR (t)2 r
l(t,k)
l (t,k)p0 2 2p HR (t) 2pqHR (t) q2 1
under the codominant model, where HR1(t) and HR2(t)
are not necessarily equal to HR0(t) or to each other.
For a locus on the X chromosome, the hazard function
for noncarriers is given by
l(t,k)
l (t,k)p ,0 p HR (t) (1 p )X X X
where , , and pX is the fre-HR (t)p HR (t) HR (t)p 01 X 2
quency of all disease alleles at that locus.
We estimated all parameters on the log scale—that is,
as ln(p), ln[HR1(t)], and ln[HR2(t)]—because on that
scale their log-likelihood profiles were close to a quad-
ratic curve. Maximum-likelihood theory, therefore, sug-
gests that their distributions are close to normal and thus
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Table 1
Number of Men with CaP, by Age at Diagnosis, for Different Categories of Family Members
AGE AT
DIAGNOSIS
(years)
NO. (%) OF AFFECTED MEN
Proband ( )np 1,476 Father ( )np 1,476 Brother ( )np 1,890 Uncle ( )np 2,552
!50 56 (3.8) 1 (.6) 2 (1.8) 0
50–54 183 (12.4) 3 (1.8) 11 (9.9) 1 (1.1)
55–59 412 (27.9) 6 (3.7) 18 (16.2) 2 (2.3)
60–64 366 (24.8) 8 (4.9) 36 (32.4) 7 (7.9)
65–69 459 (31.1) 25 (15.3) 33 (29.7) 11 (12.4)
70–74 0 35 (21.5) 8 (7.2) 22 (24.7)
75–79 0 34 (20.9) 1 (0.9) 20 (22.5)
80–85 0 34 (20.9) 2 (1.8) 17 (19.1)
85 0 17 (10.4) 0 9 (10.1)
Total 1,476 163 111 89
valid variance estimates are obtainable from the asymp-
totic covariance matrix.
The probability that a male with i disease alleles de-
velops CaP at age t, in calendar-year group k (so as to
allow for an effect of PSA testing on incidence rate), is
given by
t1
l (t,1) exp  l (s,1)ds for kp 1 ,[ ]i  i
0
t t11
l (t,2) exp  l (s,1)ds l (s,2)ds for kp 2 ,[ ]i  i  i
0 t 11
where t1 is the male’s age in 1992. The probability that
a male does not develop the disease before age t, in
calendar-year group , is given bykp 2
t t1
exp  l (s,1)ds l (s,2)ds ,[ ] i  i
0 t 11
where indicates the number of disease alleles.ip 0, 1, 2
For a two-locus model, without loss of generality, we
assume dominant inheritance for the first locus and X-
linked inheritance for the second. The interaction be-
tween the effects of these two loci was allowed to be
multiplicative or additive. Under a multiplicative model,
the hazard ratio for carriers of both a dominant and X-
linked risk is given by , where HRd is the
′HR #HRd X
hazard ratio for carriers of the dominant risk and
the hazard ratio for carriers of the X-linked risk;′HRX
under an additive model, the hazard ratio is HR d
. The correlations between the estimates of pairs of′HRX
model parameters (e.g., the dominant andX-linked allele
frequencies and the dominant and X-linked hazard ra-
tios) were estimated from the asymptotic correlationma-
trix given by MENDEL (Lange et al. 1988).
Nested models were compared using the likelihood-
ratio test; otherwise, we used Akaike’s (1974) infor-
mation criterion (AIC), defined as AICp 2(maximum
log-likelihood  no. of parameters estimated). The AIC
serves as a measure for assessing the relative fits of un-
nested models by adding a penalty to each log-likelihood
to reflect the number of parameters estimated under a
particular model. The parsimonious model was taken to
be that with the minimum AIC.
To examine the possible effects of the introduction of
PSA testing, we conducted sensitivity analyses. The age
and disease status of all relatives were assumed to be
the age and disease status present at the beginning of
1992. To identify the families that were most likely to
be contributing to a particular major-gene effect (dom-
inant, recessive, codominant, or X linked), we calcu-
lated, for each family, the change that occurred in log-
likelihood when that effect was included in a single-locus
model, compared with a null model, in which the effect
was not included.
Results
Descriptive Statistics and Analysis of Cohorts of
Relatives
A total of 1,476 families (based on 437 probands liv-
ing in Sydney, 786 in Melbourne, and 253 in Perth)
contained 8,836 male relatives, of whom 363 (4%) had
been diagnosed with CaP. Approximately 80% of the
probands (1,192/1,476) did not have a father with CaP
or any brothers or uncles with CaP; two probands had
three affected brothers; five probands had three affected
lineal uncles; and four probands had four affected
relatives.
Table 1 shows that 11% (163/1,476) of fathers, 6%
(111/1,890) of brothers, and 3.5% (89/2,552) of lineal
uncles had been diagnosed with CaP. The median age
at diagnosis of CaP was 61 years (mean 61 years, SD 6
years) for the probands, 62 years (mean 63 years, SD 6
years) for the affected brothers, 75 years (mean 74 years,
SD 8 years) for the affected fathers, and 75 years (mean
75 years, SD 8 years) for the affected lineal uncles.
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Figure 1 Age-specific cumulative probability of CaP for the pop-
ulation and for brothers, fathers, and lineal uncles of the probands
who had CaP at age !70 years.
Figure 1 shows the cumulative probability of CaP for
the Australian population and for cohorts defined by the
brothers, fathers, and lineal uncles of the proband. By
the mid-1990s, ∼1% of Australian men were diagnosed
with CaP at age !65 years, 5% at age !75 years, and
12% at age !85 years (Giles et al. 1998). For the broth-
ers, ∼8% (95% confidence interval [CI] 6%–10%) were
affected by age 65 years and 18% (95% CI 14% - 22%)
were affected by age 75 years. When we used data (age
and disease status) collected from brothers prior to 1992,
5% were affected by age 70 years, but this estimate was
based on just 20 cases, and there was little information
on brothers beyond that age. For fathers, ∼9% (95%
CI 7%–11%) were affected by age 75 years. There also
appeared to be a small excess risk in lineal uncles, at
least by age 75 years when ∼6% (95%CI 4%–8%) were
affected. There was no discernible difference between
paternal and maternal uncles ( , ).2x p 3.1 Pp .08(1)
Segregation Analyses—Single-Locus Models
Table 2 (top half) shows the best-fitting single-locus
models for different modes of inheritance. Under dom-
inant inheritance alone, the log hazard ratio was best
described by a quadratic function of age (i.e., inb p 03
eq. [1]). The cumulative probability of CaP in carriers
of at least one copy of the disease allele was estimated
to be 7%, 36%, and 79% to ages 60, 70, and 80 years,
respectively. These cumulative probability estimates
were not changed greatly when different polynomial
models for ln[HRi(t)] were fitted. Under the assumption
of constant hazard ratio (results not shown), the esti-
mated allele frequency was .011 (95% CI .006–.021),
and the hazard ratio was 36 (95% CI 27–47).
Under recessive inheritance alone, the best-fitting
model of the log hazard ratio was a cubic function of
age. The cumulative probability of CaP in homozygote
carriers was 14%, 62%, and 96% to ages 60, 70, and
80 years, respectively. Again, the estimated penetrances
did not change greatly for different polynomial models.
Under the assumption of constant hazard ratio (results
not shown), the estimated allele frequency was .15 (95%
CI .11–.20), and the hazard ratio was 43 (95% CI
27–70). The estimates under codominant inheritance
were similar to those under recessive inheritance.
Under X-linked inheritance alone, the best-fitting
model of log hazard ratio was a cubic function of age.
The cumulative probability of CaP in carriers of the X-
linked risk was 20%, 75%, and 99% to ages 60, 70,
and 80 years, respectively. Under the assumption of con-
stant hazard ratio, the estimated allele frequency was
.01 (95% CI .004–.022), and the hazard ratio was 62
(95% CI 36–108). On the basis of AIC, the recessive
model was the most parsimonious single mode-of-in-
heritance model.
Segregation Analyses—Two-Locus Models
Table 2 (bottom half) shows the best-fitting two-locus
models under the multiplicative assumption; we found
that the fits were better if it was assumed that the in-
teraction effects were multiplicative rather than additive
(results not shown). The two-locus recessive X-linked
model is not shown because it was not possible to derive
estimates, owing to the lack of convergence of the max-
imization algorithm, presumably reflecting the collinear-
ity of parameters describing these two modes of inher-
itance when this family design was used. In all two-locus
models, the best-fitting description of the log hazard ra-
tio was a quadratic function of age. The two-locus mod-
els gave a better fit than did the single-locus models. As
judged on the basis of AIC and the likelihood-ratio tests,
the dominant  recessive multiplicative model gave a
better fit than did the dominant  X-linked model. The
strength of dominant effect, in terms of the allele fre-
quency and hazard ratio, was reduced by incorporation
of a recessive or X-linked effect. Under the multiplicative
assumption, the cumulative probability of CaP to age
80 years in carriers of the dominant risk decreased from
75% to either 69%, when a recessive risk was added,
or to 72%, when an X-linked risk was added; on the
other hand, the cumulative probability of CaP for car-
riers of the recessive risk was increased by incorporation
of a dominant effect, increasing from 91% to 100% by
age 80 years. The corresponding probability for carriers
of the X-linked risk also was increased, from 69% to
100%by age 80 years, after incorporation of a dominant
effect.
The correlation coefficients between the estimates of
the allele frequencies for the two modes of inheritance
were small and not significant, being .09 and .07 under
multiplicative dominant  X-linked and dominant 
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Figure 2 Estimated hazard ratios and cumulative probabilities under two-locus multiplicative models
recessive models, respectively. Similarly, the correlation
coefficients between the estimates of hazard ratios of the
two modes of inheritance were all !.20 and not statis-
tically significant.
Figure 2a and b shows the estimated best-fitting quad-
ratic hazard ratios under the two-locus models, plotted
on a log scale. Similar graphs were evident from fits that
allowed for the hazard ratios to be a cubic function of
age. The hazard ratio for the dominantly inherited risk
decreased rapidly, from ∼800 at age 50 years to 10 at
age 70 years. The hazard ratio for the X-linked risk
increased from 25 at age 50 years to 110 at age 70 years
and then stabilized at that level. The hazard ratio for
the recessively inherited risk increased from 40 at age
50 years to ∼180 at age 70 years; that is, the dominant
risk was more evident at earlier ages, whereas the X-
linked and recessive risks were more evident at later ages.
Figure 2c and d shows the estimated cumulative prob-
ability of CaP for carriers of the dominantly inherited,
X-linked, and recessively inherited risks, based on the
estimates given in the bottom half of table 2. The pen-
etrance for carriers of the X-linked risk increased rapidly,
from 19% to 89% and 100% at ages 60, 70, and 80
years, respectively, similar to the penetrance for carriers
of the recessive risk, which increased from 23% to 94%
and 100% at the same ages; irrespective of the mode of
inheritance at the other locus, the penetrance for carriers
of the dominant risk increased from 7% to 18% and
72%, at the same ages.
Table 3 shows the 10 families for which the change
in log-likelihood was greatest as a result of addition of
an X-linked single-locus effect to a null model. These
families have either multiple brothers affected or lineal
maternal uncles affected, if not both. Nine probands
were diagnosed at age 60 years, and 80% (14/18) of
the affected brothers were diagnosed at age !65 years.
The three affected maternal uncles, however, were di-
agnosed at age 170 years.
Table 3 also shows the 10 families that provided the
most evidence for a recessively inherited risk. These fam-
ilies also have either multiple affected brothers or an
affected father or uncles. More than 60% (9/14) of af-
fected brothers were diagnosed at age !60 years. Seven
families had an affected father, compared with only two
families in the X-linked situation. Five families contrib-
uted both to the 10 families most influential for the X-
linked mode of inheritance and to the 10 families most
influential for the recessive mode of inheritance. Finally,
table 3 shows the 10 families that provided the most
evidence for a dominantly inherited risk, 8 of which also
contributed to those for the recessive model and 4 of
which contributed to those for the X-linked model.
We performed two sets of sensitivity analyses, using
the age and disease status of relatives prior to 1992 and
only first-degree relatives of the probands. Both of the
two-locus models still gave a better fit than did the single-
locus model, irrespective of how we restricted the data
from relatives. Estimates of the allele frequency were
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Table 3
Age at Diagnosis of All Affected Members of 10 Families for Which the Change in Log-Likelihood
was Greatest When an X-Linked, Recessive, and Dominant Effect Was Added to the Null Model
INHERITANCE AND
FAMILY ID
AGE(S) AT DIAGNOSIS
(years)
DLLaProband Father Brother(s) Uncle(s)
X linked:
VIC1216 51 … 61, 68 74b (Maternal) 7.15
VIC50 60 … 59, 66, 67 … 6.77
VIC895 54 … 52, 58 … 6.61
VIC1335 58 72b 57, 60 … 5.85
VIC1805 49 64b … 74b (Maternal); 54b, 70b (Paternal) 5.10
WA2300 59 … 59,63 5.09
VIC1290 52 … 61 74b (Maternal) 4.90
NSW621 57 … 64b, 64b … 4.88
NSW831 53 … 63, 65 … 4.81
NSW54 61 … 62, 66 … 4.54
Recessive:
VIC1335 58 72b 57, 60 … 6.69
VIC895 54 … 52, 58 … 6.09
VIC1805 49 64b … 74b (Maternal); 54b, 70b (Paternal) 5.83
VIC1216 51 … 61, 68 74b (Maternal) 5.39
NSW770 55 78b 54 … 5.33
VIC1132 55 80b 52b … 5.11
VIC479 55 54b 66b … 5.08
VIC50 60 … 59, 66, 67 … 5.04
NSW780 55 80b 53 … 4.96
WA1605 60 71b 60 77 (Paternal) 4.89
Dominant:
VIC1335 58 72b 57, 60 … 5.98
VIC1805 49 64b … 74b (Maternal); 54b, 70b (Paternal) 5.41
VIC895 54 … 52,58 … 5.15
NSW817 55 72 … 76, 82, 82 (Paternal) 5.09
VIC1216 51 … 61, 68 74b (Maternal) 4.91
VIC479 55 54b 66b … 4.66
NSW770 55 78b 54b … 4.50
VIC1637 55 70b 54b … 4.42
VIC1132 55 80b 52b … 4.39
WA1605 60 71b 60 77 (Paternal) 4.38
a Change in log-likelihood, compared with the null model.
b Diagnosed before 1992.
smaller when data on relatives were censored. For ex-
ample, under the constant–hazard-ratio assumption and
the multiplicative two-locus model, the allele frequency
for the dominant risk was ∼.01, irrespective of whether
the other locus was recessive or X-linked, comparedwith
.03 when data for all relatives were used, and the esti-
mated constant hazard ratio was stable, at ∼15. The
estimated allele frequency for the X-linked risk was
.0001, compared with .005 when data for all relatives
were used. Also, the estimated allele frequency of the
recessive risk became .05, compared with .08. The es-
timated constant hazard ratio did not change much for
the dominant risk; however, it became ∼60 and ∼160
for the recessive and X-linked risks, respectively.
For the recessive effect, the allele frequency decreased
from .08 to .05 when the relatives were censored, and
the constant hazard ratio decreased from 110 to 60, with
the cumulative probability to age 70 years decreasing
from 91% to 75%. For the X-linked effect, the allele
frequency decreased from .005 to .001, although the
constant hazard ratio increased from 90 to 160, and the
cumulative probability to age 70 years increased from
86% to 97%.
When we used only first-degree relatives of the pro-
bands, the estimated allele frequency was slightly higher,
with a wider 95% CI, than when we used all relatives.
The estimated allele frequency of the dominant risk be-
came .04, whereas the estimated allele frequency for re-
cessive and X-linked risks became .09 and .007, respec-
tively. The estimated constant hazard ratio for the
dominant risk became ∼20, whereas for recessive and
X-linked risk it became ∼100 and ∼80, respectively.
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Discussion
Our two-locus segregation analysis, of families with CaP
that included uncles of probands, has confirmed the
likely genetic heterogeneity of CaP. Segregation analyses
aim to detect genetic factors that have a major effect on
an individual’s risk of disease; hence, the term “major
gene effects” is often used. For CaP we have found that
such effects could include two or more of the following:
(1) dominantly inherited risks contributing especially to
early-onset disease, (2) X-linked risks, and (3) recessively
inherited risks, the latter two appearing to contribute
more to later-onset disease. Recent linkage and other
molecular studies have identified several autosomal
regions, as well as one region on the X chromosome,
that may contain genes contributing a (dominantly) in-
herited risk (Ostrander and Stanford 2000).
Most of the previous segregation studies have been
single-locus and restricted to nuclear families. They have
tended to favor a dominantly inherited risk for CaP
(Steinberg et al. 1990; Gronberg et al. 1994; 1996;
Hayes et al. 1995; Page et al. 1997). However, some
studies have claimed evidence of an X-linked or reces-
sively inherited risk, on the basis of the observation that
relative risk due to the presence of an affected brother
is greater than that due to the presence of an affected
father or son (Monroe et al. 1995; Narod et al. 1995).
To the best of our knowledge, ours is the first segre-
gation analysis of CaP that has fitted two-locus models
and that has used more than just nuclear families. We
found stronger evidence for the co-occurrence of both
the dominant and the nondominant modes of inheri-
tance than for the occurrence of either mode alone. The
penetrance associated with the nondominant effects ap-
pears to be considerably higher than that for the dom-
inant effects, even after the data on relatives are cen-
sored so as not to include cases identified by the recent
epidemic of PSA-detected CaP in Australia (see below).
It was not possible, however, with the family structure
of our design, to discriminate between recessive and X-
linked effects.
The introduction of PSA testing during the early
1990s in Australia has led to a dramatic increase in the
incidence of CaP in the subsequent years. Recent sta-
tistical modeling (Etzioni et al. 1998) has suggested that
∼50% of new cases in the United States would have
been unlikely to have come to clinical diagnosis in the
absence of PSA testing. There is also evidence that men
with CaP diagnosed by PSA testing are ∼3–5.5 years
younger than those with CaP diagnosed by either digital
rectal examination or physical symptoms (Gann et al.
1995; Pearson et al. 1996). In the present study, 82%
(91/111) of brothers, compared with 20% (32/163) of
fathers and 33% (29/89) of uncles, were diagnosed dur-
ing or after 1992. To adjust for the changing incidence
of CaP over time, we used calendar-time–specific base-
line incidences—namely, a lower incidence before 1992
and a higher incidence after 1992—based on Australian
cancer-registry data.
We only fitted models for genetic factors that had a
strong influence on individual risk. It is possible that
familial aggregation could also be due to nongenetic
factors shared by relatives. Some segregation analyses
claim to fit, if not exclude, so-called “environmental
models,” through a convenient but limited parameter-
ization of the transmission probabilities. In reality, the
family environment could act in many and much more
sophisticated ways. Family and twin analyses of con-
tinuous traits have demonstrated that evidence for ef-
fects of family environment can be inferred from mod-
eling of the familial trait correlations, through use of
both genetic relationship and cohabitation status, pro-
vided that the design is such that genetic and nongenetic
effects are not highly confounded (as is usually the case
with nuclear-family–alone designs); for example, see the
report by Harrap et al. (2000). Therefore, interpretation
of our model fits must take into account that at least a
component of familial aggregation could be due to non-
genetic familial factors. In the present study, our aim
has not been to tease apart the unmeasured effects of
genes and environment, which would be better done by
specialized designs such as those involving twin or adop-
tee families; instead, our aim has been to try to make
inferences about the types and characteristics of major-
gene effects, primarily to assist efforts aimed at gene
discovery.
Environmental or lifestyle factors associated with a
substantial risk of disease have yet to be identified.
However, given that there is a high prevalence of latent
CaP in older men, familial aggregation could, in part,
be due to diagnostic zeal. This has become of particular
importance in recent years, with the advent of PSA test-
ing. Screening behavior is likely to be correlated within
families, particularly between brothers: an unaffected
man whose brother has been recently diagnosed with
CaP could be prompted to have a PSA test himself,
leading to a diagnosis of CaP at an age much earlier
than when it otherwise would have occurred (if ever).
To assess the impact of PSA testing on our model fits,
we conducted sensitivity analyses, by ignoring infor-
mation on relatives collected since the beginning of
1992. We found that the estimates of allele frequency
and penetrance for the dominantly inherited risk were
robust to this censoring. For the recessive effect, both
the allele frequency and cumulative probability de-
creased slightly. For the X-linked effect, however, there
was a substantial decrease in the estimate of the allele
frequency, as well as an increase in the estimate of the
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cumulative probability. The instability of estimates for
the nondominant effects may be due to the reduction
in the number of incident cases among relatives, espe-
cially among brothers. Nevertheless, despite ignoring all
cases in relatives since 1992, we still found evidence of
nondominant genetic effects in addition to dominantly
inherited ones. The most realistic model probably lies
somewhere between that fitted with all data of relatives
and that with the censoring of data at the beginning of
1992.
We modeled the increased risk in carriers by multi-
plying the age-specific population incidence by a factor
(the hazard ratio) and fitted polynomial functions for
the log hazard ratio. We used the flexibility of this set
of functions to examine nonconstant or nonlinear trends
of multiplicative genetic risks in carriers. Implementa-
tion of this strategy led to detection of both a decreasing
trend with age, for the dominant hazard ratio, and an
increasing trend with age, for the X-linked and recessive
hazard ratio, at early ages. Both of these trends tended
to dissipate at later ages (fig. 2); that is, in multiplicative
terms there were quantitatively different patterns for the
dominantly inherited increased risk, which was greater
at earlier ages, compared with the nondominant risks,
which were greater at later ages. This is of interest, given
that the linkage study of Schleutker et al. (1999) found
evidence for X linkage in families with later mean ages
at onset and with relatively few cases, in contrast with
the studies finding evidence for dominantly inherited
risk at the putative HPC1 region, confined mostly to
families with multiple cases of early mean age at di-
agnosis (Smith et al. 1996; Cooney et al. 1997; Hsieh
et al. 1997; Xu et al. 2000).
Nevertheless, our family data still combine both CaP
diagnosed prior to PSA testing (in the majority of af-
fected fathers and uncles) and CaP diagnosed during the
PSA-testing era (in all probands and in the great ma-
jority of brothers); that is, the phenotype does not nec-
essarily have the same definition within a family. (This
phenomenon is probably having a major impact on CaP
linkage studies, by inducing phenocopies.) In addition
to the sensitivity analyses, we have attempted to obtain
some uniformity of phenotype definition within and be-
tween families, by excluding from recruitment as pro-
bands those newly diagnosed cases who had a Gleason
score !5; that is, we have focused on clinically signifi-
cant CaP. Nevertheless, we are still likely to have in-
cluded a proportion of probands who would not have
been diagnosed if not for PSA testing. CaP is a biolog-
ically heterogeneous disease. One way to increase dis-
ease specificity is to retrieve archival tissue and to per-
form immunohistochemical studies in order to define
homogenous subgroups for future reanalysis. We are
pursuing this approach.
The question remains as to the identity of the pop-
ulation about which we are making inferences. We have
sampled families through probands with clinically sig-
nificant CaP diagnosed at age !70 years. Therefore, the
genes that are apparently segregating in these families
are those which are most likely to cause such early-onset
disease. We have, in effect, estimated the penetrance of
these genes through use of the disease history of the
relatives of the probands, as has been done for muta-
tions in BRCA1 and BRCA2 through use of the families
of known mutation carriers (Hopper et al. 1999). In
doing so, we have estimated the penetrance function to
ages beyond the latest age at diagnosis of the probands.
In summary, our analyses need to be interpretedwithin
the usual caveats that apply to segregation analyses; in
particular, that they are trying to determine the best-
fitting geneticmodels, not to differentiate betweengenetic
effects and a broad range of plausible environmental ef-
fects. Furthermore, PSA testing has created problems in
terms of disease definition and may be contributing to
the high incidence rate that has been seen in brothers
since 1992—and, thereby, artifactually may be giving
more credence to models that include nondominant
modes of inheritance. Nevertheless, our analyses suggest
that there may be multiple sources of genetic risks for
CaP, involving autosomal genes associated with domi-
nantly and recessively inherited risks, as well as one or
more genes on the X chromosome. Therefore, in addition
to further exploration of dominant inheritance of CaP,
future linkage studies might benefit from consideration
of recessive effects of high penetrance and should con-
tinue to examine the X chromosome, for the presence of
cancer-susceptibility genes. The findings in the present
study may have implications for future efforts in gene
discovery.
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